B cell depletion in the treatment of multiple sclerosis-Reference-Cited by-同舟云学术

B cell depletion in the treatment of multiple sclerosis

Published:2019-01-23 Issue:3 Volume:19 Page:261-271
ISSN:1471-2598
Container-title:Expert Opinion on Biological Therapy
language:en
Short-container-title:Expert Opinion on Biological Therapy

Author:

Myhr Kjell-Morten¹²,Torkildsen Øivind¹²,Lossius Andreas³⁴,Bø Lars¹²,Holmøy Trygve³⁵

Affiliation:

1. Department of Clinical Medicine, University of Bergen, Bergen, Norway

2. Department of Neurology, Haukeland University Hospital, Bergen, Norway

3. Department of Neurology, Akershus University Hospital, Lørenskog, Norway

4. Department of Immunology and Transfusion Medicine, Faculty of Medicine, University of Oslo and Oslo University Hospital Rikshospitalet, Oslo, Norway

5. Department of Clinical Medicine, University of Oslo, Oslo, Norway

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14712598.2019.1568407

Reference94 articles.

1. Multiple sclerosis

2. The cost of multiple sclerosis in Norway

3. The economic impact of multiple sclerosis to the patients and their families in Norway

4. Survival and cause of death in multiple sclerosis: results from a 50-year follow-up in Western Norway

5. Disease‐modifying treatments for multiple sclerosis – a review of approved medications

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Planned dose reduction of ocrelizumab in relapsing-remitting multiple sclerosis: a single-centre observational study;BMJ Neurology Open;2024-06

2. The patient-reported wearing-off phenomenon with monoclonal antibody treatments for multiple sclerosis;Multiple Sclerosis Journal - Experimental, Translational and Clinical;2024-04

3. Multiple Sclerosis: Roles of miRNA, lcnRNA, and circRNA and Their Implications in Cellular Pathways;International Journal of Molecular Sciences;2024-02-13

4. Autologous hematopoietic stem cell transplantation for multiple sclerosis: Long-term follow-up data from Norway;Multiple Sclerosis Journal;2024-02-12

5. B cell depletion therapy does not resolve chronic active multiple sclerosis lesions;eBioMedicine;2023-08